Wednesday’s Midday Movers: SunPower (SPWR), Peabody Energy Comm (BTU), Invivo Therapeutics Holdings (NVIV), La Jolla Pharma (LJPC), Novavax (NVAX)

So far Wednesday, February 12, NASDAQ is down -0.44% and the S&P is up 0.07%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; SunPower (SPWRResearch Report), Peabody Energy Comm (BTUResearch Report), Invivo Therapeutics Holdings (NVIVResearch Report), La Jolla Pharma (LJPCResearch Report) and Novavax (NVAXResearch Report).

SunPower is up 7.74% in midday trading to $11.00. Shares opened today at $10.21. The company has a 52-week low of $5.72 and a 52-week high of $16.04. On the Street’s front, the average 12-month analyst price target for the stock is $7.38, marking a -27.72% potential downside from current levels. In a report issued on February 4, Roth Capital analyst Philip Shen initiated coverage with a Hold rating on SPWR and a price target of $9.00, which represents a potential downside of 12% from where the stock is currently trading. Separately, on December 16, Morgan Stanley’s Stephen Byrd maintained a Sell rating on the stock and has a price target of $5.80. In the last 30 days, insiders purchased $12.44K worth of SPWR shares.

Peabody Energy Comm is down -6.81% in midday trading to $7.66. Shares opened today at $8.22. The company has a 52-week low of $6.45 and a 52-week high of $30.54. On the Street’s front, the average 12-month analyst price target for the stock is $11.00, marking a 33.82% potential upside from current levels. In a report issued on February 7, The Benchmark Company analyst Mark Levin initiated coverage with a Hold rating on BTU. Separately, on February 6, Deutsche Bank’s Chris Terry maintained a Buy rating on the stock and has a price target of $12.00. In the last 30 days, insiders have sold $90.81K worth of BTU shares. Over the last 3 months, the insider sentiment on Peabody Energy Comm has been positive based on 121 corporate insider transactions. This sentiment is slightly higher than the average sector sentiment of insiders.

Invivo Therapeutics Holdings is down -6.8% in midday trading to $6.99. Shares opened today at $7.50. The company has a 52-week low of $3.69 and a 52-week high of $52.14.

See today’s analyst top recommended stocks >>

La Jolla Pharma is down -6.38% in midday trading to $8.28. Shares opened today at $8.84. The company has a 52-week low of $2.30 and a 52-week high of $13.90. On the Street’s front, the average 12-month analyst price target for the stock is $11.33, marking a 28.17% potential upside from current levels. In a report issued on January 24, LifeScience Cap analyst Sam Slutsky maintained a Buy rating on LJPC, with a price target of $11.00, which represents a potential upside of 24% from where the stock is currently trading. Separately, on January 9, H.C. Wainwright’s Edward White maintained a Hold rating on the stock . In the last 30 days, insiders purchased $18.59M worth of LJPC shares. Over the last 3 months, the insider sentiment on La Jolla Pharma has been positive based on 90 corporate insider transactions. This sentiment is slightly higher than the average sector sentiment of insiders.

Novavax is up 6.18% in midday trading to $7.65. Shares opened today at $7.20. The company has a 52-week low of $3.54 and a 52-week high of $44.60. On the Street’s front, the average 12-month analyst price target for the stock is $17.38, marking a 141.39% potential upside from current levels. In a report issued on January 27, Ladenburg Thalmann analyst Michael Higgins maintained a Buy rating on NVAX, with a price target of $27.50, which implies an upside of 282% from current levels. Over the last 3 months, the insider sentiment on Novavax has been negative based on 10 corporate insider transactions. This sentiment is lower than the average sector sentiment of insiders.

See today’s analyst top recommended stocks >>

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.